Rural Response to the Opioid Crisis – Resources
Selected recent or important resources focusing on Rural Response to the Opioid Crisis.
Treatment Initiations and Opioid Overdoses among Recently Incarcerated People after Adoption of the Take-Home Methadone Policy
Explores the effect flexible methadone policies implemented during the COVID-19 pandemic had on opioid overdoses and treatment initiation and uptake among incarcerated people upon release. Highlights the effect this policy had on rural areas and communities that lack access to opioid treatment.
Author(s): Benjamin A. Barsky, Shapei Yan, Meredith B. Rosenthal
Citation: Drug and Alcohol Dependence, 274, 112775
Date: 09/2025
view details
Explores the effect flexible methadone policies implemented during the COVID-19 pandemic had on opioid overdoses and treatment initiation and uptake among incarcerated people upon release. Highlights the effect this policy had on rural areas and communities that lack access to opioid treatment.
Author(s): Benjamin A. Barsky, Shapei Yan, Meredith B. Rosenthal
Citation: Drug and Alcohol Dependence, 274, 112775
Date: 09/2025
view details
Introducing Public Health Vending Machines in Rural Communities: Protocol for a Study Using a Community-Based Participatory Approach
Provides a study protocol focused on creating a community-engaged approach to implementing public health vending machines (PHVMs) that distribute naloxone in rural North Carolina. Discusses the need to engage people who have experienced substance use when developing public health interventions to prevent drug overdose.
Author(s): Meghan Guter, Lauren Harrell, Kathleen L Egan, Reese Hiatt, Lori Ann Eldridge
Citation: JMIR Research Protocols, 14
Date: 09/2025
view details
Provides a study protocol focused on creating a community-engaged approach to implementing public health vending machines (PHVMs) that distribute naloxone in rural North Carolina. Discusses the need to engage people who have experienced substance use when developing public health interventions to prevent drug overdose.
Author(s): Meghan Guter, Lauren Harrell, Kathleen L Egan, Reese Hiatt, Lori Ann Eldridge
Citation: JMIR Research Protocols, 14
Date: 09/2025
view details
Modeling the Impact of Changing Drug Markets and Structural Determinants on HCV and/or HIV Transmission Among People Who Inject Drugs in the United States: A Rural and Urban Comparison
Details a study exploring the impact of changing patterns of drug use in rural and urban areas are affecting the rates of hepatitis C virus (HCV) and HIV incidence among people who inject drugs (PWID). Compares rates of infection and drug use in San Diego, CA and rural Central and Northern, WI.
Author(s): Natasha K. Martin, Daniela Abramovitz, William H. Eger, et al.
Citation: International Journal of Drug Policy, 143, 104925
Date: 09/2025
view details
Details a study exploring the impact of changing patterns of drug use in rural and urban areas are affecting the rates of hepatitis C virus (HCV) and HIV incidence among people who inject drugs (PWID). Compares rates of infection and drug use in San Diego, CA and rural Central and Northern, WI.
Author(s): Natasha K. Martin, Daniela Abramovitz, William H. Eger, et al.
Citation: International Journal of Drug Policy, 143, 104925
Date: 09/2025
view details
Medications for Opioid Use Disorder among Adults Who Had an Opioid Use Disorder
Offers National Survey on Drug Use and Health (NSDUH) data on adults receiving medications for opioid use disorder (MOUD) between 2022 and 2024 by age, sex, region, and metropolitan county status.
Date: 09/2025
Sponsoring organization: Substance Abuse and Mental Health Services Administration
view details
Offers National Survey on Drug Use and Health (NSDUH) data on adults receiving medications for opioid use disorder (MOUD) between 2022 and 2024 by age, sex, region, and metropolitan county status.
Date: 09/2025
Sponsoring organization: Substance Abuse and Mental Health Services Administration
view details
Marijuana Use or Opioid Misuse in the Past Year
Highlights National Survey on Drug Use and Health (NSDUH) data on marijuana and opioid use between 2022 and 2024. Includes break down of use for adults and adolescents between 12 and 17 by various demographic and geographic factors including 5 levels of urbanization.
Date: 09/2025
Sponsoring organizations: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration
view details
Highlights National Survey on Drug Use and Health (NSDUH) data on marijuana and opioid use between 2022 and 2024. Includes break down of use for adults and adolescents between 12 and 17 by various demographic and geographic factors including 5 levels of urbanization.
Date: 09/2025
Sponsoring organizations: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration
view details
Examining Geographic Disparities in Access to No-Cost Naloxone in North Carolina: A Cross-Sectional Survey of Naloxone Distribution Programs
Presents a study exploring the geographic distribution of no-cost naloxone in North Carolina. Bases findings on a survey of naloxone distributors in the state and breaks down data by user demographics and distributor type.
Author(s): Grace Marley, Caroline Shubel, Carolyn T. Thorpe, et al.
Citation: Journal of Rural Health, 41(3), e70069
Date: 08/2025
view details
Presents a study exploring the geographic distribution of no-cost naloxone in North Carolina. Bases findings on a survey of naloxone distributors in the state and breaks down data by user demographics and distributor type.
Author(s): Grace Marley, Caroline Shubel, Carolyn T. Thorpe, et al.
Citation: Journal of Rural Health, 41(3), e70069
Date: 08/2025
view details
Expanding the Opioid Use Disorder Medication Treatment Workforce in Rural Communities Through the RCORP Initiative
Examines the impact of the Rural Communities Opioid Response Program (RCORP) on the workforce supply of Drug Enforcement Administration (DEA)-waivered clinicians in rural areas, who are able to prescribe buprenorphine. Analyzes 2017–2022 DEA lists of waivered clinicians to report on counties with a waivered clinician, clinician-to-population ratios, and treatment slot-to-population ratios. Discusses the impact of RCORP funding on Opioid Use Disorder (OUD) recovery services in rural communities.
Author(s): C. Holly A. Andrilla, Sara C. Woolcock, Kathleen Meyers, Davis G. Patterson
Citation: Journal of Rural Health, 41(1), e12867
Date: 07/2025
view details
Examines the impact of the Rural Communities Opioid Response Program (RCORP) on the workforce supply of Drug Enforcement Administration (DEA)-waivered clinicians in rural areas, who are able to prescribe buprenorphine. Analyzes 2017–2022 DEA lists of waivered clinicians to report on counties with a waivered clinician, clinician-to-population ratios, and treatment slot-to-population ratios. Discusses the impact of RCORP funding on Opioid Use Disorder (OUD) recovery services in rural communities.
Author(s): C. Holly A. Andrilla, Sara C. Woolcock, Kathleen Meyers, Davis G. Patterson
Citation: Journal of Rural Health, 41(1), e12867
Date: 07/2025
view details
The Opioid Epidemic in Rural Communities: Can Telehealth Increase Access to Medication for Opioid Use Disorder and Offset Barriers to Care?
Examines the impact of telehealth on access to medication for opioid use disorder (MOUD) and substance use disorder (SUD) and opioid use disorder (OUD) treatment. Utilizes data from the Rural Communities Opioid Response Program's (RCORP) consortia, the National Survey of Drug Use and Health (NSDUH), and the U.S. Census Bureau's American Community Survey (ACS) to analyze access to MOUD and rates of telehealth use for rural consortia. Discusses potential barriers and factors impacting telehealth implementation for SUD and OUD care.
Author(s): Kathleen Meyers, Shannon Herman, Heather Schuler, et al.
Citation: Drug and Alcohol Dependence, 271, 112628
Date: 06/2025
view details
Examines the impact of telehealth on access to medication for opioid use disorder (MOUD) and substance use disorder (SUD) and opioid use disorder (OUD) treatment. Utilizes data from the Rural Communities Opioid Response Program's (RCORP) consortia, the National Survey of Drug Use and Health (NSDUH), and the U.S. Census Bureau's American Community Survey (ACS) to analyze access to MOUD and rates of telehealth use for rural consortia. Discusses potential barriers and factors impacting telehealth implementation for SUD and OUD care.
Author(s): Kathleen Meyers, Shannon Herman, Heather Schuler, et al.
Citation: Drug and Alcohol Dependence, 271, 112628
Date: 06/2025
view details
Effects of Using Different Rural Measurements on Estimates of Hospitalizations for Depression and Substance Use
Explores how using different rural measurements can affect estimates of hospitalization rates for behavioral health conditions. Highlights how Rural-Urban Commuting Areas (RUCA) codes, Core-Based Statistical Areas (CBSA), Urban-Rural Category 4 (URCategory4), and Rural-Urban Continuum Codes (RUCC) affect hospitalization estimates. Discusses the consequences these difference can have on policy.
Author(s): Robin Danek, Justin Blackburn, Marion Greene, et al.
Citation: BMC Health Services Research, 25, 818
Date: 06/2025
view details
Explores how using different rural measurements can affect estimates of hospitalization rates for behavioral health conditions. Highlights how Rural-Urban Commuting Areas (RUCA) codes, Core-Based Statistical Areas (CBSA), Urban-Rural Category 4 (URCategory4), and Rural-Urban Continuum Codes (RUCC) affect hospitalization estimates. Discusses the consequences these difference can have on policy.
Author(s): Robin Danek, Justin Blackburn, Marion Greene, et al.
Citation: BMC Health Services Research, 25, 818
Date: 06/2025
view details
Evaluation of the Maternal Opioid Misuse (MOM) Model: Fourth Annual Report (Implementation Year 3)
Provides an overview of the Maternal Opioid Misuse Model, which provides evidence-based integrated care and care coordination for pregnant and postpartum Medicaid beneficiaries with opioid use disorder (OUD). Describes activities MOM Model awardees undertook during the MOM Model's second implementation year, July 1, 2023–June 30, 2024, and summarizes qualitative and beneficiary-level process data findings by state awardee. Discusses barriers pregnant and postpartum women with OUD face in accessing high-quality, continuous care, specifically in rural areas.
Additional links: Findings at a Glance
Date: 06/2025
Sponsoring organizations: Centers for Medicare & Medicaid Services, Westat
view details
Provides an overview of the Maternal Opioid Misuse Model, which provides evidence-based integrated care and care coordination for pregnant and postpartum Medicaid beneficiaries with opioid use disorder (OUD). Describes activities MOM Model awardees undertook during the MOM Model's second implementation year, July 1, 2023–June 30, 2024, and summarizes qualitative and beneficiary-level process data findings by state awardee. Discusses barriers pregnant and postpartum women with OUD face in accessing high-quality, continuous care, specifically in rural areas.
Additional links: Findings at a Glance
Date: 06/2025
Sponsoring organizations: Centers for Medicare & Medicaid Services, Westat
view details
Additional resources are available related to this guide. See the full list of resources by topic for: